CCK8 peptide derivatized with diphenylphosphine for rhenium labelling: Synthesis and molecular mechanics calculations

被引:10
作者
Morelli, G
De Luca, S
Tesauro, D
Saviano, M
Pedone, C
Dolmella, A
Visentin, R
Mazzi, U
机构
[1] CIRPEB, I-80134 Naples, Italy
[2] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy
[3] Univ Padua, Dipartimento Sci Farmaceut, I-35131 Padua, Italy
关键词
CCK8; derivatives; molecular mechanics calculations; rhenium-peptide complex; solid-phase peptide synthesis;
D O I
10.1002/psc.400
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel CCK8 derivative bearing a chelating agent at its N- end and its oxo-rhenium(V) complex have been synthesized and characterized. The chelating agent N-{N-[3-(diphenylphosphino)propionyl]glycyl}cysteine (PN2S) ligand, the coordination set of which is made by the phosphorus atom of phosphine, the nitrogen atoms of the two amido groups and the sulphur atom of cysteine, has been used due to its high affinity towards the oxo-rhenium(V) moiety. Molecular modelling studies indicate that the CCK8 peptide adopts the right conformation for cholecystokinin receptor binding, and that modifications on the N-terminal side of CCK8 obtained by introducing chelating agents and its metal complexes should not affect the interaction with CCKA receptor. Copyright (C) 2002 European Peptide Society and John Wiley Sons, Ltd.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 20 条
[1]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[2]   Synthesis and solution characterization of a porphyrin-CCK8 conjugate [J].
De Luca, S ;
Tesauro, D ;
Di Lello, P ;
Fattorusso, R ;
Saviano, M ;
Pedone, C ;
Morelli, G .
JOURNAL OF PEPTIDE SCIENCE, 2001, 7 (07) :386-394
[3]   Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor [J].
Giragossian, C ;
Mierke, DF .
BIOCHEMISTRY, 2001, 40 (13) :3804-3809
[4]  
Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO
[5]  
2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO
[6]  
2-X]
[7]   Receptor targeting for tumor localisation and therapy with radiopeptides [J].
Heppeler, A ;
Froidevaux, S ;
Eberle, AN ;
Maecke, HR .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (09) :971-994
[8]   Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling [J].
Ji, ZS ;
Hadac, EM ;
Henne, RM ;
Patel, SA ;
Lybrand, TP ;
Miller, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (39) :24393-24401
[9]   Identification of two amine acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin [J].
Kennedy, K ;
Gigoux, V ;
Escrieut, C ;
Maigret, B ;
Martinez, J ;
Moroder, L ;
Frehel, D ;
Gully, D ;
Vaysse, N ;
Fourmy, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) :2920-2926
[10]   PREPARATION OF OXOPENTACHLORORHENATE(VI) AND OXOTETRACHLORORHENATE(V) - CRYSTAL AND MOLECULAR-STRUCTURE OF ASPH4REOCL4 [J].
LIS, T ;
JEZOWSKATRZEBIATOWSKA, B .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1977, 33 (APR15) :1248-1250